GET THE APP

Neurodegeneration - A Means to an End
Journal of Cell Science & Therapy

Journal of Cell Science & Therapy
Open Access

ISSN: 2157-7013

+44 1300 500008

Editorial - (2012) Volume 3, Issue 3

Neurodegeneration - A Means to an End

Amit Singh*
Department of Biology, Premedical Program, Center for Tissue Regeneration and Engineering at Dayton (TREND), University of Dayton, Dayton, OH 45469, USA
*Corresponding Author: Amit Singh, Department of Biology, Premedical Program, Center for Tissue Regeneration and Engineering at Dayton (TREND), University of Dayton, Dayton, OH 45469, USA, Tel: 937-229-2894, Fax: 937-229-2021 Email:

Cell death, a global phenomenon found throughout the animal kingdom, is a mechanism to maintain tissue homeostasis and for adaptation to changes in the environment [1,2]. Millions of cells die in our body daily- they succumb to stress and commit suicide by a mechanism referred to as cell death or apoptosis [2-4]. Under normal conditions cells are continuously replaced by new cells from the stemor progenitor- cells. For example, an optimum balance in shedding of dead cells from the skin and their replenishment by new ones maintain our health and hygiene. In this context, apoptosis is a mechanism to eliminate cells that are no longer useful. Apoptosis has also emerged as an important player during development when programmed cell death (PCD) is triggered to eliminate extra cells and to sculpt the final form of an organ. PCD is a crucial developmental process for the removal of problematic or unnecessary cells in multi cellular organisms [5,6].

Programmed cell death is also employed for refining the nervous system both in vertebrates as well as invertebrates [7]. In the nervous system the outcome of cell death is not favorable. The basic building blocks of the nervous system are neurons and glial cells. The neurons are post-mitotic cells and unlike the skin cells or the cells of the intestinal lining these cells are not renewed. Therefore, loss of neurons in the central nervous system always has consequences. It has been estimated that there are three billion neurons in the human brain. The hallmark of neurodegenerative disorders is loss of neurons over a period of time. Initially, there is a room to accommodate the loss of some neurons by generation of new neuronal network by generating de novo dendritic connections. The loss of neurons beyond a certain threshold can no longer be accommodated. Therefore, the loss of neurons over a period of time compounds the effect and manifest in terms of progressive neurodegenerative disorders. Since this loss of neurons takes place along a time axis therefore it is also referred to as progressive neurodegenerative disorder or age related disease. The hallmark of these disorders is the loss of cognitive functions like learning and memory. All diseases that affect neuronal health have been classified as neurodegenerative disorders. Some of the neurodegenerative disorders are: Alzheimer’s disease, Huntington’s, Parkinson’s, Amyloid lateral Sclerosis (ALS) [8-10]. All these disease have genetic basis which effect various different sub-cellullar organelle. Here we take example of the Alzheimer’s disease to ascertain the effects:

Alzheimer’s disease has been shown to be an outcome of genetic mutations, which may have significant bearing on intracellular mechanisms like protein-degradation pathways, mitochondrial dysfunction, axonal transport and cell death mechanisms [8-10]. The major effect of neurodegeneration in Alzheimer’s disease is generation of amyloid-beta 42 (Aß42) oligomers, which due to their hydrophobic nature tend to make plaques [11-14]. These Aß42 are highly toxic and result in triggering neurodegeneration. Another reason for onset of neurodegeneration in AD is called tauopathy [8-11]. The tauopathy is an outcome of degeneration of the microtubule of the neurons into neurofibrillary tangles. Microtubules are important part of the cytoskeleton of the cells, which are used by motor proteins to transfer the cargo from the cell body of the neuron to the presynaptic membrane of the neuron. Microtubules are a polymer of different isomers of tubulin which join to form the protofilament. These protofilaments are linked together to form the hollow microtubule by proteins called MAPs (microtubule aasociation proteins). In tauopathy mediated neurodegeneration the hyperphosphorylation of MAPs results in disintegration of the neurons, which prevents the transport and as a result causes stress and onset of neurodegeneration.

Death rules our existence. Cell death is a safe mechanism for disposal of malfunctioning, damaged, excess and/or pathogen-infected cells or debris and is crucial to keep us alive and healthy. On the contrary uncontrolled or mislocalized cell death can be deleterious as observed in neurodegenerative disorders.

References

  1. Wickman G, Julian L, Olson MF (2012) How apoptotic cells aid in the removal of their own cold dead bodies. Cell Death Differ 19: 735-742.
  2. Conradt B (2009) Genetic control of programmed cell death during animal development. Annu Rev Genet 43: 493-523.
  3. Fan Y, Bergmann A (2008) Apoptosis-induced compensatory proliferation. The Cell is dead. Long live the Cell! Trends Cell Biol 18: 467-473.
  4. Perl M, Denk S, Kalbitz M, Huber-Lang M (2012) Granzyme B: a new crossroad of complement and apoptosis. Adv Exp Med Biol 946: 135-146.
  5. Elliott MR, Ravichandran KS (2010) Clearance of apoptotic cells: implications in health and disease. J Cell Biol 189: 1059-1070.
  6. Baehrecke EH (2002) How death shapes life during development. Nat Rev Mol Cell Biol 3: 779-787.
  7. Rusconi JC, Hays R, Cagan RL (2000) Programmed cell death and patterning in Drosophila. Cell Death Differ 7: 1063-1070.
  8. Rincon-Limas DE, Jensen K, Fernandez-Funez P (2012) Drosophila Models of Proteinopathies: the Little Fly that Could. Curr Pharm Des 18: 1108-1122.
  9. Pandey UB, Nichols CD (2011) Human disease models in Drosophila melanogaster and the role of the fly in therapeutic drug discovery. Pharmacol Rev 63: 411-436.
  10. Moloney A, Sattelle DB, Lomas DA, Crowther DC (2010) Alzheimer's disease: insights from Drosophila melanogaster models. Trends Biochem Sci 35: 228-235.
  11. Zou WQ, Xiao X, Yuan J, Puoti G, Fujioka H,et al. (2011) Amyloid-beta42 interacts mainly with insoluble prion protein in the Alzheimer brain. J Biol Chem 286: 15095-15105.
  12. Tare M, Modi RM, Nainaparampil JJ, Puli OR, Bedi S, et al. (2011) Activation of JNK signaling mediates amyloid-ß-dependent cell death. PLoS One 6: e24361.
  13. Ling D, Song HJ, Garza D, Neufeld TP, Salvaterra PM (2009) Abeta42-induced neurodegeneration via an age-dependent autophagic-lysosomal injury in Drosophila. PLoS One 4: e4201.
  14. Hardy J (2009) The amyloid hypothesis for Alzheimer's disease: a critical reappraisal. J Neurochem 110: 1129-1134.
Citation: Singh A (2012) Neurodegeneration - A Means to an End. J Cell Sci Ther 3:e107.

Copyright: © 2012 Singh A. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Top